Doubling Expression of the Low Density Lipoprotein Receptor by Truncation of the 3′-Untranslated Region Sequence Ameliorates Type III Hyperlipoproteinemia in Mice Expressing the Human ApoE2 Isoform
Authors:
Open Access
- 1 February 2001
- journal article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 276 (6) , 3856-3862
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- The role of the LDL receptor in apolipoprotein B secretionJournal of Clinical Investigation, 2000
- Apo E structure determines VLDL clearance and atherosclerosis risk in miceJournal of Clinical Investigation, 1999
- Reversal of Hypercholesterolemia in Apolipoprotein E2 and Apolipoprotein E3-Leiden Transgenic Mice by Adenovirus-Mediated Gene Transfer of the VLDL ReceptorArteriosclerosis, Thrombosis, and Vascular Biology, 1998
- Hypercholesterolemia in low density lipoprotein receptor knockout mice and its reversal by adenovirus-mediated gene delivery.Journal of Clinical Investigation, 1993
- Spontaneous Hypercholesterolemia and Arterial Lesions in Mice Lacking Apolipoprotein EScience, 1992
- Molecular cloning and nucleotide sequence of cDNA encoding a functional murine low-density-lipoprotein receptorSomatic Cell and Molecular Genetics, 1992
- Ability of the LDL receptor from several animal species to recognize the human apo B binding domain: studies with LDL from familial defective apo B-100Atherosclerosis, 1992
- Familial apolipoprotein E deficiency.Journal of Clinical Investigation, 1986
- The human LDL receptor: A cysteine-rich protein with multiple Alu sequences in its mRNACell, 1984
- The metabolism of very low density lipoprotein proteins I. Preliminary in vitro and in vivo observationsBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1972